PK/PD Relationship of the Monoclonal Anti-BAFF Antibody Tabalumab in Combination with Bortezomib in Patients with Previously Treated Multiple Myeloma: Comparison of Serum M-protein and Serum Free Light Chains as Predictors of Progression Free Survival

Comments are closed.